Control of galectin gene expression

Biochimie

Volumn 81, Issue 4, 1999, Pages 381-388

  Chiariotti, Lorenzo ^a   Salvatore, Paola ^a,b   Benvenuto, Giovanna ^a   Bruni, Carmelo Bruno ^a  

^a Dipto Biol e Patol Cell e Molec   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Galectins; Gene expression; Transcriptional regulation; Tumor progression

Indexed keywords

GALECTIN;

CELL TRANSFORMATION; GENE EXPRESSION REGULATION; MAMMAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION; TUMOR GROWTH;

EUKARYOTA; MAMMALIA;

EID: 0032707151     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)80085-6     Document Type: Article

References (66)

1. Barondes S.H., et al. Galectins: a family of animal β-galactoside-binding lectins. Cell. 76:1994;597-598.
2. Barondes S.H., Cooper D.N.W., Gitt M.A., Leffler H. Structure and function of a large family of animal lectins. J. Biol. Chem. 269:1994;20807-20810.
3. Barondes S.H. Galectins: a personal overview. Trends Glycosci. Glycotech. 9:1997;1-7.
4. Leffler H. Introduction to galectins. Trends Glycosci. Glycotech. 9:1997;9-19.
5. Sanford G.L., Harris-Hooker S. Stimulation of vascular cell proliferation by beta-galactoside specific lectins. FASEB J. 4:1990;2912-2918.
6. Wells V., Mallucci L. Identification of an autocrine negative growth factor: mouse β-galactoside-binding protein is a cytostatic factor and cell growth regulator. Cell. 64:1991;91-97.
7. Yamaoka K., Ohno S., Kawasaki H., Suzuki K. Overexpression of a β-galactoside binding protein causes transformation of BALB3T3 fibroblast cells. Biochem. Biophys. Res. Commun. 179:1991;272-279.
8. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature. 378:1995;736-739.
9. Pace K.E., Baum L.G. Induction of T lymphocyte apoptosis: a novel function for galectin-1. Trends Glycosci. Glycotech. 9:1997;21-29.
10. Vyakarnam A., Dagher S.F., Wang J.L., Patterson R.J. Evidence for a role for galectin-1 in pre-mRNA splicing. Mol. Cell. Biol. 17:1997;4730-4737.
11. Akahani S., Nangia-Makker P., Inohara H., Choi Kim H.R., Raz A. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 57:1997;5272-5276.
12. Dagher S.F., Wang J.L., Patterson R.L. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc. Natl. Acad. Sci. USA. 92:1995;1213-1217.
13. Akahani S., Inohara H., Nangia-Makker P., Raz A. Galectin-3 in tumor metastasis. Trends Glycosci. Glycotech. 9:1997;69-75.
14. Frigeri L.G., Robertson M.W., Liu F.T. Expression of biologically active recombinant rat IgE-binding protein in Escherichia coli, J. Biol. Chem. 1990;20763-20769.
15. Yamaoka A., Kuwabara I., Frigeri L.G., Liu F.T. A human lectin, galectin-3 (ebp/Mac-2), stimulates superoxide production by neutrophils. J. Immunol. 154:1995;3479-3487.
16. Gitt M.A., Colnot C., Poirier F., Nani K.J., Barondes S.H., Leffler H. Galectin-4 and galectin-6 are two closely related lectins expressed in mouse gastrointestinal tract. J. Biol. Chem. 273:1998;2954-2960.
17. Gitt M.A., Jordan E.T., Leffler H. Galectin-2, galectins-5 and -9, and galectins-4 and-6. Trends Glycosci. Glycotech. 9:1997;87-93.
18. Madsen P., Rasmussen H.H., Flint T., Gromov P., Kruse T.A., Honoré B., Vorum H., Celis J.E. Cloning, expression, and chromosome mapping of human galectin-7. Mol. Cell. Biol. 270:1995;5823-5829.
19. Magnaldo T., Brnerd F., Darmon M. Galectin-7, a human 14-kDa S-lectin, specifically expressed in keratinocytes and sensitive to retinoic acid. Dev. Biol. 168:1995;259-271.
20. Magnaldo T., Darmon M. Galectin-7, a new marker of mammalian stratified epithelia. Trends Glycosci. Glycotech. 9:1997;95-102.
21. Magnaldo T., Fowlis D., Darmon M. Galectin-7, a marker of all types of stratified epithelia. Differentiation. 3:1998;59-168.
22. Hadari Y.R., Paz K., Dekel R., Mestrovic T., Accili D., Zick Y. Galectin-8. A new rat lectin, related to galectin-4. J. Biol. Chem. 17:1995;3447-3453.
23. Hadari Y.R., Eisenstein M., Zakut R., Zick Y.B. Galectin-8: on the road from structure to function. Trends Glycosci. Glycotech. 9:1997;103-112.
24. Wada J., Ota K., Kumar A., Wallner E.I., Kanwar Y.S. Developmental regulation, expression, and apoptotic potential of galectin-9, a β-galactoside binding lectin. J. Clin. Invest. 99:1997;2452-2461.
25. Tureci O., Schmitt H., Fadle N., Pfreundschuh M., Sahin U. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J. Biol. Chem. 272:1997;6416-6422.
26. Leal-Pinto E., Tao W., Rappaport J., Richardson M., Knorr B.A., Abramson R.G. Molecular cloning and functional reconstitution of a urate transporter/channel. J. Biol. Chem. 272:1997;617-625.
27. Dyer K.D., Rosenberg H.F. Eosinophil Charcot-Leyden crystal protein binds to beta-galactoside sugars. Life Sci. 58:1996;2073-2082.
28. Gitt M.A., Xia Y.R., Atchison R.E., Lusis A.J., Barondes S.H., Leffler H. Sequence, structure, and chromosomal mapping of the mouse Lgals6gene, encoding galectin-6. J. Biol. Chem. 273:1998;2961-2970.
29. Colnot C., Ripoche M.A., Fowlis D., Cannon V., Scaerou F., Cooper D., Poirier F. The role of galectins in mouse development. Trends Glycosci. Glycotech. 9:1997;31-40.
30. Cooper D. Galectin-1: secretion and modulation of cell interactions with laminin. Trends Glycosci. Glycotech. 9:1997;57-67.
31. Key B., Puche A.C. Role of galectin-1 in the olfactory nervous system. Trends Glycosci. Glycotech. 9:1997;41-45.
32. Baum L.G., Pang M., Perillo N.L., Wu T., Delegeane A., Fukuda M., Uittenbogaart C., Seilhamer J.J. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to oligosaccharides on thymocytes and T lymphoblastoid cells. J. Exp. M. 181:1995;877-887.
33. Chiariotti L., Berlingieri M.T., DeRosa P., Battaglia C., Berger N., Bruni C.B., Fusco A. Increased expression of the negative growth factor, galactoside-binding protein gene in transformed thyroid cells and in human thyroid carcinomas. Oncogene. 7:1992;2507-2511.
34. Chiariotti L., Benvenuto G., Salvatore P., Veneziani B.M., Villone G., Fusco A., Russo T., Bruni C.B. Expression of the soluble lectin L-14 gene is induced by TSH in thyroid cells and suppressed by retinoic acid in transformed neural cells. Biochem. Biophys. Res. Commun. 199:1994;540-546.
35. Gillenwater A., Xu X.C., Estrov Y., Sacks P.G., Lotan D., Lotan R. Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate. Int. J. Cancer. 75:1998;217-224.
36. Baum L.G., Seilhamer J.J., Pang M., Levine W.B., Beynon D., Berliner J.A. Synthesis of an endogenous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation. Glycoconj. J. 12:1995;63-68.
37. Chiariotti L., Benvenuto G., Zarrilli R., Rossi E., Salvatore P., Colantuoni V., Bruni C.B. Activation of the galectin-1 (L-14-I) gene from non-expressing differentiated cells by fusion with undifferentiated and tumorigenic cells. Cell Growth Differ. 5:1994;769-775.
38. Hébert E., Roche A.C., Nachtigal M., Monsigny M. Transformation but not ras-transfection increases the expression of galectin-3 in human HOS cells. C.R. Acad. Sci. III. 319:1996;871-877.
39. Nangia-Makker P., Ochieng J., Christman J.K., Raz A. Regulation of the expression of galactoside-binding lectin during human monocytic differentiation. Cancer Res. 53:1993;5033-5037.
40. Hsu D.K., Hammes S.R., Kuwabara I., Greene W.C., Liu F.T. Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the β-galactoside-binding lectin, galectin-3. Am. J. Pathol. 148:1996;1661-1670.
41. Chiariotti L., Berlingieri M.T., Battaglia C., Benvenuto G., Martelli M.L., Salvatore P., Chiappetta G., Bruni C.B., Fusco A. Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors. Int. J. Cancer (Pred. Oncol.). 64:1995;171-175.
42. Xu X.C., El-Naggar A.K., Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am. J. Pathol. 147:1995;815-822.
43. Fernandez P.L., Merino M.J., Gomez M., Campo E., Medina T., Castronovo V., Sanjuan X., Cardesa A. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J. Pathol. 181:1997;80-86.
44. Orlandi F., Saggiorato E., Pivano G., Puligheddu B., Termine A., Cappia S., De Giuli P., Angeli A. Galectin-3 is a pre-surgical marker of human thyroid carcinoma. Cancer Res. 58:1998;3015-3020.
45. Lotz M.M., Andrews C.W., Korzelius C.A., Lee E.C., Steele G.D., Clarke A., Mercurio A.M. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc. Natl. Acad. Sci. USA. 90:1993;3466-3470.
46. Castronovo V., Campo E., Van Den Brûle F.A., Claysmith A.P., Cioce V., Liu F.T., Fernandez P.L., Sobel M.E. Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. J. Natl. Cancer Inst. 84:1992;1161-1169.
47. Schoeppner H.L., Raz A., Ho S.B., Bresalier R.S. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer. 75:1995;2818-2826.
48. Irimura T., Matsushita Y., Sutton R.C., Carralero D., Ohannesian D.W., Cleary K.R., Ota D.M., Nicolson G.L., Lotan R. Increased content of an endogenous lactose-binding lectin in human colorectal carcinomas progressed to metastatic stages. Cancer Res. 51:1991;387-393.
49. Sanjuàn X., Fernandez P.L., Castells A., Castronovo V., Van Den Brûle F., Liu F.T., Cardesa A., Campo E. Differential expression of galectin-3 and galectin-1 in colorectal cancer progression. Gastroenterology. 113:1997;1906-1915.
50. Bresalier R.S., Mazurek N., Sternberg L.R., Byrd J.C., Yunker K., Nangia-Makker P., Raz A. Metastasis of human colon cancer cells is altered by modifying expression of the beta-galactoside binding protein galectin-3. Gastroenterology. 115:1998;287-296.
51. Rechreche H., Mallo G.V., Montalto G., Dagorn J.C., Iovanna J.L. Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer. Eur. J. Biochem. 248:1997;225-230.
52. Lotan R., Ito H., Yasui W., Yokozaki H., Lotan D., Tahara E. Expression of a 31-kDa galactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas. Int. J. Cancer. 56:1994;474-480.
53. Konstantinov K.N., Robbins B.A., Liu F.T. Galectin-3, a β-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. Am. J. Pathol. 148:1996;25-30.
54. Bresalier R.S., Yan P.S., Byrd J.C., Lotan R., Raz A. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer. 80:1997;776-787.
55. Castronovo V., Van Den Brûle F.A., Jackers P., Clausse N., Liu F.T., Gillet C., Sobel M.E. Decreased expression of galectin-3 is associated with progression of human breast cancer. J. Pathol. 179:1996;43-48.
56. Van DenBrûle F.A., Berchuck A., Bast R.C., Liu F.T., Gillet C., Sobel M.E., Castronovo V. Differential expression of 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur. J. Cancer. 30:1994;1096-1099.
57. Østergaard M., Rasmussen H.H., Nielsen H.V., Vorum H., Ørntoft T.F., Wolf H., Celis J.E. Proteome profiling of bladder squamous cell carcinomas: Identification of markers that define their degree of differentiation. Cancer Res. 57:1996;4111-4117.
58. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
59. Su Z.Z., Lin J., Shen R., Fisher P.E., Goldstein N.I., Fisher P.B. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc. Natl. Acad. Sci. USA. 93:1996;7252-7257.
60. Pienta J.K., Naik H., Akhtar A., Yamazaki K., Replogle T.S., Lehr J., Donat T.T., Tait L., Hogan V., Raz A. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J. Natl. Cancer Inst. 87:1995;348-353.
61. Salvatore P., Contursi C., Benvenuto G., Bruni C.B., Chiariotti L. Characterization and functional dissection of the galectin-1 gene promoter. FEBS Lett. 373:1995;159-163.
62. Benvenuto G., Carpentieri M.L., Salvatore P., Cindolo L., Bruni C.B., Chiariotti L. Cell-specific transcriptional regulation and reactivation of galectin-1 gene expression are controlled by DNA methylation of the promoter region. Mol. Cell. Biol. 16:1996;2736-2743.
63. Salvatore P., Benvenuto G., Caporaso M., Bruni C.B., Chiariotti L. High resolution methylation analysis of the galectin-1 gene promoter region in expressing and nonexpressing tissues. FEBS Lett. 421:1998;152-158.
64. Kadrofske M.M., Kyle P.O., Wang J.L. The human LGALS3 (Galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch. Biochim. Biophys. 349:1998;7-20.
65. Raimond J., Rouleux F., Monsigny M., Legrand A. The second intron of the human galectin-3 gene has a strong promoter activity down-regulated by p-53. FEBS Lett. 363:1995;165-169.
66. Gomolin H., Yamaguchi Y., Paulpillai A.V., Dvorak L.A., Ackerman S.J., Tenen D.G. Human eosinophil Charcot-Leyden crystal protein: cloning and characterization of a lysophospholipase gene promoter. Blood. 82:1993;1868-1874.